ERBB2 and breast cancer: As a heterogeneous disease, BC encompasses various subtypes characterized by distinct expression patterns of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), such as Luminal A, Luminal B, Basal-like, and HER2-positive [3].